Behçet’s Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity?

Table 3

Laboratory findings of our patients at presentation.

Laboratory value	Patient A	Patient B	Patient C	Normal range
Hematocrit	36.5	38.1	38.3	40.0–52.0%
Hemoglobulin	12	12.1	12.3	13–17.8 g/dL
MCV	90	81.8	83	80−99 fL
Leukocytes	8.60	9.83	9.80	4.0−10 × 10^3/μL
Neutrophils	59	74	74.2	40−75%
Lymphocytes	32	14.1	21.3	20−45%
Platelets	262	513	304	150−450 × 10^3/μL
PT	11	𝟔𝟏.𝟒^∗	14.1	10.5–12.5 sec
apTT	30	𝟑𝟗.𝟑^∗	52.5	27–34 sec
d-dimers	0.1	1.0	2.6	0–0.3 μg/mL
Fibrinogen	3.88	5.8	5.8	2–4 g/L
∗patient B was on acenocoumarol therapy when tested
Total Proteins	7.9	7.20	8.10	5.5–8 g/dL
Albumin	4.6	3.40	4.20	3.5–5.5 g/dL
Globulins	3.3	3.80	3.90	1.5–3.5 g/dL
ESR	38	52	80	1−10 mm/1rst hour
C-reaction Protein	3.55	9.54	10.10	<0.80 mg/dL
IgA	171	409	501	85−450 mg/dL
IgG	1736	958	1136	800−1700 mg/dL
IgM	170	37	57	63−277 mg/dL
C3 complement	170	213	126	85–193 mg/dL
C4 complement	53	33.6	41	12–36 mg/dL
RF	<15	<15	<15	0–20 IU/mL
ANA	Negative	Negative	Negative
Anti-DNA	Negative	Negative	Negative
P-ANCA	Negative	Negative	Negative
C-ANCA	Negative	Negative	Negative
Anti-ENA	Negative	Negative	Negative
HLA type	𝚩^∗𝟓𝟏	𝚩^∗𝟓𝟏	𝚩^∗𝟓𝟏−𝐁^∗𝟐𝟕
R.P.R.	Negative	Negative	Negative
HBsAg	Negative	Negative	Negative
IgM anti-HBc	Negative	Negative	Negative
Anti-HCV	Negative	Negative	Negative
H.I.V Ag/Ab Combo	Negative	Negative	Negative